Concurrent Chemoradiotherapy versus Intensity-modulated Radiotherapy Alone for Elderly Nasopharyngeal Carcinoma Patients with Pre-treatment Epstein-Barr Virus DNA: A Cohort Study in an Endemic Area with Long-term Follow-up-Reference-Cited by-同舟云学术

Concurrent Chemoradiotherapy versus Intensity-modulated Radiotherapy Alone for Elderly Nasopharyngeal Carcinoma Patients with Pre-treatment Epstein-Barr Virus DNA: A Cohort Study in an Endemic Area with Long-term Follow-up

Published:2018 Issue:17 Volume:9 Page:3023-3031
ISSN:1837-9664
Container-title:Journal of Cancer
language:en
Short-container-title:J. Cancer

Author:

Yang Qin,Zhao Ting-Ting,Qiang Meng-Yun,Hu Liang,Lv Xing,Ye Yan-Fang,Ke Liang-Ru,Yu Ya-Hui,Qiu Wen-Ze,Liu Guo-Ying,Huang Xin-Jun,Li Wang-Zhong,Lv Shu-Hui,Sun Yao,Zhang Lu-Yao,Pei Fei,Guo Xiang,Xiang Yan-Qun,Qian Chao-Nan,Huang Bi-Jun,Xia Wei-Xiong

Publisher

Ivyspring International Publisher

Subject

Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy in elderly patients with locoregionally advanced nasopharyngeal carcinoma;Radiotherapy and Oncology;2024-11

2. Concurrent chemoradiotherapy versus radiotherapy alone in older patients with stage II nasopharyngeal carcinoma after intensity-modulated radiotherapy: A propensity score-matched cohort study;Radiotherapy and Oncology;2024-02

3. Chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Who really needs it;Cancer Medicine;2022-12-09

4. Institutionally validated nomogram predicting prognosis for older patients with nonmetastatic nasopharyngeal carcinoma;Future Oncology;2022-05

5. Adding Concurrent Chemotherapy Significantly Improves the Survival of Stage II-IVb Nasopharyngeal Carcinoma Patients Treated With Concurrent Anti-EGFR Agents;Frontiers in Oncology;2021-12-17